Related Experiment Video
Updated: Apr 23, 2026

Measuring Local Anaphylaxis in Mice
Published on: October 14, 2014
[Drug-related anaphylactic shocks: under-reporting and PMSI]
Hadyl Asfari1, Cédric Bousquet1, Béatrice Trombert Paviot1
1INSERM, U1142, LIMICS, Paris, France ; Sorbonne Universités, UPMC Université Paris 6, UMRS 1142, LIMICS, Paris, France ; Université Paris 13, Sorbonne Paris Cité, LIMICS (UMRS 1142), Villetaneuse, France - Service de santé publique et d'information médicale, Centre hospitalier universitaire de Saint-Étienne - Hôpital Nord, Saint-Étienne, France.
Aim:
To evaluate the value of research in the case-mix database to identify cases of drug-related anaphylactic or anaphylactoid shock.
Methods:
Hospital stays of patients discharged from the University Hospital of Saint-Étienne between July 1st 2009 and June 30th 2012. Five codes from the international classification of diseases were selected: T88.6, T88.2, J39.3, T80.5 and T78.2.
Results:
Among 89 cases identified by the programme for medicalization of information system (programme de médicalisation des systèmes d'information, PMSI), 40 were selected (45%). Of these, 16 cases were spontaneously reported by physicians. The unspecific code "anaphylactic shock unspecified (T78.2)" was coded for 57.5% of cases.
Conclusion:
The study confirms the interest of the PMSI as a tool for health monitoring, in addition to spontaneous reporting. Nevertheless, coding with insufficient precision about the causal role of the drug, requires a return to the medical record and so an important time consuming process.
Related Concept Videos
Allergic Reactions: Anaphylaxis
Allergic Reactions
Measurement of Blood Pressure
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Pharmaceutical Poisoning: Potential Scenarios
Hypersensitivity Reactions: Delayed Hypersensitivity Reactions

